CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $450,000
- in 1 filing
Net −$450,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 43 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-14 | Shojaei Amir CHIEF SCIENTIFIC OFFICER | Option exercise | +11,250 | $35.96 | $405K | 11,250 |
| 2026-08-14 | Shojaei Amir CHIEF SCIENTIFIC OFFICER | Sale | −11,250 | $40.00 | $450K | 0 |
| 2026-08-14 | Shojaei Amir CHIEF SCIENTIFIC OFFICER | Option exercise · Stock Option (Right to Buy) | −11,250 | $35.96 | $405K | 18,750 |
| 2026-06-18 | Sternberg Perry J. Director | Grant or award · RSU | +5,248 | 5,248 | ||
| 2026-06-18 | SILVERNAIL LAUREN P Director | Grant or award · RSU | +5,248 | 5,248 | ||
| 2026-06-18 | Graves Adrienne L Director | Grant or award · RSU | +5,248 | 5,248 | ||
| 2026-05-18 | Graves Adrienne L Director | Purchase | +1,000 | $31.07 | $31K | 1,000 |
| 2026-05-18 | SILVERNAIL LAUREN P Director | Purchase | +1,000 | $31.00 | $31K | 1,000 |
| 2026-05-15 | Shojaei Amir CHIEF SCIENTIFIC OFFICER | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2026-05-14 | BAUM MARK L CHIEF EXECUTIVE OFFICER | Purchase | +10,000 | $30.20 | $302K | 2,996,130 |
| 2026-05-14 | BOLL ANDREW R. PRESIDENT AND CFO | Purchase | +3,500 | $29.90 | $105K | 814,679 |
| 2026-03-04 | Opaleye Management Inc. 10% owner | Sale | −134,000 | $39.67 | $5.3M | 3,622,000 |
| 2026-03-04 | Opaleye Management Inc. 10% owner | Sale | −4,263 | $39.67 | $169K | 59,428 |
| 2026-03-03 | Opaleye Management Inc. 10% owner | Sale | −59,000 | $39.15 | $2.3M | 3,756,000 |
| 2026-03-03 | Opaleye Management Inc. 10% owner | Sale | −1,309 | $39.15 | $51K | 63,691 |
| 2026-02-27 | Opaleye Management Inc. 10% owner | Sale | −5,000 | $54.18 | $271K | 65,000 |
| 2026-01-30 | Sullivan Patrick William CHIEF COMMERCIAL OFFICER | Grant or award · RSU | +25,000 | 25,000 | ||
| 2026-01-30 | Sullivan Patrick William CHIEF COMMERCIAL OFFICER | Grant or award · RSU | +15,000 | 15,000 | ||
| 2026-01-06 | Opaleye Management Inc. 10% owner | Sale | −20,000 | $53.35 | $1.1M | 70,000 |
| 2025-12-12 | BOLL ANDREW R. PRESIDENT AND CFO | Option exercise | +60,000 | $3.95 | $237K | 837,844 |
Page 1 of 17 · 336 trades